All Articles

Fabry nephropathy: focus on podocyte damage and therapeutic target

In memory of Nathan A. Berger, MD

The diagnostic odyssey, clinical burden, and natural history of Barth syndrome: an analysis of patient registry data

Commentary on “transcription regulation by long non-coding RNAs: mechanisms and disease relevance”

Unraveling the genetic tapestry of neurodevelopmental disorders: a new horizon

The reactive stroma response regulates the immune landscape in prostate cancer

Duchenne muscular dystrophy: diagnosis and perspective of treatment

The potential therapeutic applications of long non-coding RNAs

Reduced protein kinase C delta in a high molecular weight complex in mitochondria and elevated creatine uptake into Barth syndrome B lymphoblasts

Challenges in determining the malignant potential of atypical neurofibromas (aNF) using histopathologic features and the potential need for CDKN2A/2B testing: a case report

Genetics in the diagnosis and treatment of cardiovascular diseases

Silent players, loud impact: unveiling the therapeutic potentials of LncRNAs

New approaches and prospects of immunotherapy and gene therapy for prostate cancer

Exploring the comorbidity between internalizing/externalizing dimensions and cognitive disengagement syndrome through twin studies: a narrative review

Molecular basis of neurocognitive dysfunction and psychosis in Alpha-Mannosidosis

An investigation of the anthropometric measurements in males with 47,XXY (Klinefelter Syndrome) from birth to five years of age and the impact of early hormonal treatment (EHT)

Tumor-associated antigen targets for novel immune-based strategies in prostate cancer

Personalised genomic medicine is shaping the future of healthcare